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Abstract
The objective of this study is to review available functional status measures (FSMs) validated for use in the
chronic obstructive pulmonary disease (COPD) population and categorizing the measures by their
commonalities to formulate a framework that supports clinicians in the selection and application of FSMs. A
literature review identifying valid and reliable measures of functional status for people with COPD was
undertaken. Measures were thematically analyzed and categorized to develop a framework for clinical
application. A variety of measures of activity levels exist, with 35 included in this review. Thematic
categorization identified five categories of measures: daily activity, impact, surrogate, performance-based, and
disability-based measures. The vast variety of FSMs available for clinicians to apply with people who have
COPD may be overwhelming, and selection must be thoughtfully based on the nature of the population
being studied/evaluated, and aims of evaluation being conducted, not simply as a standard measure used at
the institution. Psychometric testing is a critical feature to a strong instrument and issues of reliability, validity,
and responsiveness need to be understood prior to measurement use. Contextual nature of measures such as
language used and activities measured is also important. A categorical framework to support clinicians in the
selection and application of FSMs has been presented in this article.
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Introduction
Functional status measures (FSMs) are instruments
generally used to evaluate the impact of a person’s
health condition on their ability to perform activities.
These measures have also been referred to as activity
(or functional status) measures, questionnaires, instru-
ments, or tools. FSMs were initially developed to
describe an individual’s participation in activities of
daily living; however, functional status is sometimes
more broadly used as a term for the evaluation of
other types of function such as social, psychological,
physiologic, and emotional. This article will use the
term FSM as it relates to the direct or indirect mea-
surement of activity by patients with chronic obstruc-
tive pulmonary disease (COPD).
Why measure activities? FSMs can provide
detailed information on what individuals do, provid-
ing a window into the daily life of patients. The devel-
opment of FSMs in the 1950s and 1960s focused on
grading disability or the degree to which patients
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required assistance in the long-term residential care
setting. However, since this time, expansion of the
application of FSMs, such as for patients with chronic
disease, has allowed clinicians to use FSMs to
describe progress secondary to the disease, or in
response to therapy.
In the past 30 years, there has been a great deal of
interest in quantifying the degree of activity limitation
for patients with COPD. During this time, activity
monitors were introduced to measure activity levels
as purportedly, a more reliable method due to their
objective nature, as opposed to the subjective nature
of FSMs. However, activity monitors have limitations
in measuring small changes in daily life and patterns
of activities in patients.1 Compared to FSMs, activity
monitors have the disadvantages of expense, limita-
tion in detecting steps in those with slow walking
speed, evaluation of predominantly lower extremity
movement, and failure in some instances to provide
information specific to what activity is being per-
formed,2 for example, making a bed versus washing
the dishes. More recently, attempts have been made to
evaluate patients with both types of measures, result-
ing in complimentary information being gathered.1
Numerous FSMs exist, most developed for pur-
poses of measuring activities in patients other than
COPD. Many have the potential to be applied in the
COPD population after the measure has undergone
appropriate psychometric testing. For example, the
Nottingham Extended Activities of Daily Living
Scale3 was developed in the 1980s for use with stroke
patients, and has now been validated for use in the
COPD population.4 This transferability of FSMs
between patient population groups has led to a vast
array of measures being available to clinicians, with a
potential for confusion over which measure is the
most appropriate for specific scenario use. Observing
patterns of uniqueness of measures led the authors of
this article to consider categorizing FSMs to support
clinicians in decision-making. Providing a categorical
framework of FSMs for the pulmonary community
would be beneficial for greater clarity in the selection
and informed application of these measures.
The purpose of this article is to review available
FSMs that have been validated for use in the COPD
population and categorizing the measures by their
commonalities. Characteristics and unique qualities
of the instruments will be highlighted, and a frame-
work for selection of a measure will be presented to
support the appropriate application of the measures
for both clinicians and researchers. The features
presented will include ease of use (reflected in time
to administer, scoring, etc.), time frame, psychometric
properties (e.g. validity, reliability, responsiveness),
and minimal clinically important difference (MCID).
Methods
Establishing the FSM categories was completed in
three phases. First, FSMs were identified that were
commonly used in COPD patients through a literature
search of PubMed and Google Scholar. Three recent
systematic reviews of FSMs were identified, pub-
lished in 2014 and 20165–7 and FSMs presented in
these systematic reviews obtained. A reference list
check of all papers included in the review was also
completed to source all FSMs for use with COPD
patients. Measures that were included in the synthesis
had to meet the following criteria:
1. Validated for use with the COPD population.
2. Documented beginning psychometric proper-
ties of the measure, reporting on validity and
reliability.
3. Published in English.
4. Full-text articles published in peer review
publications.
5. Tools publicly available to review.
Instruments were excluded if they were not found
to have been used in COPD patients, were never
tested or used beyond the initial development after 5
years or more, have not been used for measurement
with the COPD population for a decade or more, or
where the scoring system changed too frequently to
reliably report the psychometric properties. Papers
considered for inclusion were reviewed by the two
authors, and consensus reached on inclusion by
discussion.
The second phase was to complete a subsequent
search of PubMed and Google Scholar to obtain cop-
ies of the measures and the literature reporting on the
psychometric properties of all FSMs identified for
inclusion. The psychometric properties of the FSMs
were then extracted from the papers by one author.
While psychometric properties often receive less
attention, inadequate testing of measures may result
in failure to obtain the desired information about the
patient/study, or provide false or misleading conclu-
sions. Responsiveness of the instrument measuring
the activity for impact of COPD or following treat-
ment (e.g. pulmonary rehabilitation) was also
recorded. The MCID of the measure was noted;
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however, as this information was not always avail-
able, papers were not excluded if MCID had not been
determined.
Descriptive analysis of the components of the
measures was then undertaken by one of the authors,
grouping papers based on the purpose of the FSM,
number of activities evaluated, how the activities
were evaluated, how the FSM was administered, and
whether it was tested and used in COPD patients.
Finally, the instruments were thematically organized
according to concepts. Initially, information on the
types of activities measured, the number of activities
evaluated, time taken to complete the entire mea-
sure, total number of items (questions) in the mea-
sure, time frame for administering, psychometric
measurement properties (as previously described),
and process of completing the measure, including
scoring and whether nominal, ordinal, or interval
scores, were extracted from the papers. The purpose
of the FSM was the primary driver in developing the
themes.
Results
A total of 61 FSMs were identified, with 35 included
in this review and thematic analysis. A list of all
FSMs reported for use with COPD patients are pro-
vided in Table 1, noting rationale for those excluded.
The main reasons for exclusion were, they had either
not been tested in the COPD population or testing was
limited to the initial instrument development.
Categories of measures
Five themes of measures were identified: daily activ-
ities, impact, surrogate, indirect performance-based,
and disability-based measures. These themes formed
five categories of measures.
1. Measures that looked at participation in a vari-
ety of activities were labeled Activity Mea-
sures. These measures evaluated the ability
of the patient to engage in numerous activities
often assessing domains of self-care, home
management, ambulation, and participation in
social and recreational activities.
2. Activities that were associated with symptoms
were labeled Impact Measures. These mea-
sures evaluated how symptoms (primarily dys-
pnea and/or fatigue) affected the person’s
ability to participate in activities. A measure
that is classically used to measure dyspnea is
the Medical Research Council (MRC)
Scale46,47; however, because this scale focuses
on the effect of dyspnea on walking limita-
tions, it could also be considered an Activity
Measure. Additionally, one could argue that
the MRC reflects disability because like the
Disability Measures, the MRC categorizes
patients as ambulatory or housebound.
3. Where activities were subscales or domains of
health status questionnaires, such as the phys-
ical function subscale of the Medical Out-
comes Study/SF-36,69 these measures were
labeled Surrogate Measures of activities.
These subscales are often used as substitutes
to establish concurrent validity of Activity
Measures; however, the activities in these Sur-
rogate Measures sometimes included evalua-
tion of emotional function making them not
purely FSMs. The domains of these health sta-
tus measures comprise part of a total score that
reflects overall health status or health-related
quality of life. Where feasible, the psycho-
metric properties of the individual domains/
subscales were reported.
4. Indirect Performance-Based Measures as a
category describes measures used to evaluate
the individual’s potential to engage in activi-
ties by observation of typical body motions.
There are limited numbers of these measures
but their contribution to understanding
patients’ limitations in activities made them
candidates as FSMs.
5. Disability-Based Measures either observe and
rate an activity or have the individual self-
report their level of independence with activi-
ties. These instruments were initially designed
for patients in long-term care settings such as
nursing homes or those limited in activity due
to stroke or orthopedic surgery.
Figure 1 provides a pictorial illustration of how
these categories address functional status. For
example, the Activity Category measures “do you
do it (the activity listed)?” In relation to activities,
the Disability Category asks, “can you do it?” and
so on.
Of the measures identified, 17 instruments were
deemed to fit in the category of Activity, 5 Impact, 5
Surrogate, 3 Performance-based, and 5 Disability-
based measures. It was noted that some measures
could be considered overlapping with other
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Table 1. List of FSMs considered for inclusion with reasons for exclusion.
Measure
Included/
excluded Reason for exclusion
Activities Checklist8 Excluded No known use in COPD patients
Activities of Daily Living Index (AKA Frenchay
Activities Index)9
Excluded No known use in COPD patients
Activities of Daily Living Inventory (ADLI)10 Excluded No known in COPD use since original development, and
limited testing
Activities of Daily Living Questionnaire (ADLQ)11 Excluded Last known use in COPD patients >10 years.
Activities of Daily Living Test12 Excluded No known use in COPD patients
Activities of Daily Living Simulation Test13 Excluded Limited psychometric testing. Performance and types of
activities altered in studies of COPD patients.
Adelaide Activities Profile (AAP)14 Excluded No known use in COPD patients
Baecke Physical Activity Questionnaire15 Excluded Types of activities designed for healthy, active elderly
Barthel Index (BI)16 Included
Barthel Index Modified (BIM)17 Included
Baseline Dyspnea/Transitional Dyspnea Index18 Included
Canadian Occupational Performance Measure
(COPM)19
Included
Capacity of Daily Living in the Morning (CDLM)20 Excluded Activities specific to morning symptoms
Chronic Respiratory Disease Questionnaire (CRQ
or CRDQ)21,22
Included
Clinical COPD Questionnaire (CCQ)23 Included
COPD Activity Rating Scale (CARS)24 Excluded First and last known use in 2003 when developed.
Community Healthy Activities Model Program for
Seniors (CHAMPS)25
Included
Customary Activity Questionnaire26 Excluded Last known use in respiratory in 1998
Duke Activity Status Index (DASI)27 Included
EuroQOL-ED 5D-5 L and VAS28,29 Included
Fitness Arthritis and Seniors Trial (FAST)30 Excluded No known use in pulmonary patients
Frenchay Activities Index (FAI)9 Excluded Multiple versions of scoring and variable number of
activities make the FAI difficult to evaluate reliably
Functional Activities Questionnaire31 Excluded No known use in COPD patients
Functional Performance Inventory (FPI)32 Included
Functional Performance Inventory (Short Form)
(FPI-SF)33
Included
Functional Status Questionnaire34 Excluded No known use in COPD patients since 1980s
Glittre Test35 Included
Groningen Activity Restriction Scale (GARS)36 Included
Human Activity Profile (HAP)37 Included
Index of Independent Activities of Daily Living Scale
(Index of ADL)38
Excluded Limited testing and little use in COPD
Instrumental Activities of Daily Living39 Excluded Last known use in COPD patients was 1994
Karnofsky Performance Scale (KPS)40 Excluded Measure of functional impairment (health to death)
London Chest Activity of Daily Living Scale
(LCADL)41
Included
London Handicap Scale42 Excluded Measure of handicap
Londrina Activities of Daily Living Protocol43 Included
Manchester Respiratory Activities of Daily Living
Questionnaire (MRADL)44
Included
Meaningful Activity Participation Assessment
(MAPA)45
Excluded Developed for those with mental illness to describe the
quality/meaningfulness of activities
Medical Research Council (MRC)46,47 Included
Milliken ADL Scale (MAS)48 Included
(continued)
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categories. For example, FSMs among the Impact
Measures were a reflection of both an individual’s
participation in activities (Activity Measure) and
symptoms with the activity (Impact). However,
because these measures ask what activities individuals
have reduced or no longer perform because of dyspnea
(e.g. Oxygen Cost Diagram, MRC, etc.), they were also
candidates for being considered Activity Measures.
Where there was overlap, these measures are noted in
the comment column of each table (Tables 1 to 5), and
explicitly presented for each FSM in Table 6. For
example, the MRC is an Impact measure, but overlaps
with both the Activity and Disability measures.
Design and psychometric properties of the FSMs
Tables 1 to 5 summarize the characteristics of each
measure, presenting measures by each of the afore-
mentioned categories. The number of activities eval-
uated is reported for each measure (specifically the
number of unique activities addressed in each mea-
sure). Those measures with more activities often
allow a better understanding of the breadth of activi-
ties affecting the patient. The fewer the activities, the
less time to complete, especially with dichotomous
(Yes/No) answers. However, Yes/No responses may
provide limited information. For example, brevity




excluded Reason for exclusion
Minnesota Leisure Time Physical Activity
Questionnaire49
Excluded Limited use in COPD patients
Monitored Functional Task Evaluation (MFTE)50 Included
Motor subscale of the Functional Independence
Measure (FIM)51
Excluded Designed for inpatient rehabilitation assessing mobility,
toilet function and cognition, not specifically evaluated
for COPD patients
Nagasaki University Respiratory Activity of Daily
Living Questionnaire52
Excluded No known use or testing since original development in
2009
Nottingham Extended Activities of Daily Living
Questionnaire (NEADL)3
Included
Oxygen Cost Diagram (OCD)53 Included
Oxford Participation and Activities Questionnaire
(Ox-PAQ)54
Excluded No known use in COPD patients
Physical Activity Scale for the Elderly (PASE)55 Included
ProActive56 Included
Pulmonary Functional Status Scale (PFSS)57 Included
Pulmonary Functional Status Scale (PFSS-11)58 Excluded Testing to limited to development
Pulmonary Functional Status Scale (Short Version)
(PFSS-35)57
Included
Pulmonary Functional Status and Dyspnea
Questionnaire (PFSDQ)59
Included
Pulmonary Functional Status and Dyspnea
Questionnaire modified version (PFSDQ-M)60
Included
Saint George’s Respiratory Questionnaire
(SGRQ)61
Included
Short Form 36 of Medical Outcomes Study (SF-
36)62
Included
Stanford 7-Day Physical Activity Recall (PAR)63 Included
The Valued Life Activity Scale64 Included
Townsends Disability Scale65 Excluded No known use in COPD patients since 1989
University of San Diego Shortness of Breath
Questionnaire (SOBQ)66
Included
Yale Physician Activity Survey (YPAS)67 Included
Zutphen Physical Activity Questionnaire (ZPAQ)68 Included
FSM: functional status measure; AKA: also known as; COPD: chronic obstructive pulmonary disease; VAS: visual analog scale.
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difficulty or the need for assistance with the activity
or if the activity is no longer performed due to a
respiratory problem. It was noted that in selected
FSMs, if the patient did not perform the activity, they
are asked to estimate their performance if they could
engage in the activity. No studies are known to eval-
uate the consequences of this type of estimate on the
validity of the data.
The types of activities evaluated are diverse across
all measures. The user should consider if the activities
of the FSM satisfy their needs for understanding their
population. For example, activities designed for a
younger or healthier older population (e.g. playing
soccer, cycling, etc.) are less relevant to patients who
are impaired from their respiratory problem or other
comorbidity such as poor balance. Activities that may
be more gender-specific may result in missing data
(e.g. cooking, washing laundry, mowing the lawn,
etc.), because these activities may not be undertaken
equally among genders. The type of scoring is impor-
tant, since some responses are dichotomous, or on a
0–10 scale, while others ask for the frequency and
time spent in the activity. Generally, the more com-
plex the scoring (e.g. weighted or reversed scoring),
the more time-consuming scoring becomes, unless a
computerized program is readily available.
Most measures reviewed were self-reports; how-
ever, some categories had predominantly observer/
assessor ratings. This was true for the Performance-
based measures. The time to take/administer the
instruments were often under 10 minutes (range 1–
20 minutes). Instruments varied in the time frame in
which the activity was performed ranging from cur-
rent to past 3 months. Time frame is a consideration if
an intervention requires more time to take effect than
identified in the FSM. Of note, the psychometrics of
the instrument may be changed if a user randomly
selects a time frame or does not utilize the entire
measure (e.g. only administers one domain of an
FSM) other than specified by the developer.
Discussion
This review of the literature has identified a diverse
range of measures available to the clinician evaluating
functional status for people with COPD. This diver-
sity likely reflects the numerous reasons why func-




Can you do it? 
E.g. BIM 
What stops you 
from doing it? 
E.g. MRC 
How likely are 
you to do it? 
E.g. Glire 
Test 
Do you do it? 
E.g. CHAMPS 
Is it contribung 
to well-being? 
E.g. SF-36 
Figure 1. An illustration of the five categories of functional status measures.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































clinical and research objectives. Considering the
diversity of measures available for use, selection must
be thoughtful based on the nature of the population
being studied, and evaluation being conducted, not
simply used because it is a standard at the institution.
The options are varied and may be overwhelming.
Through categorizing the FSMs and providing a sum-
mary of design and psychometric properties of the
measures, this article aims to guide clinicians and
researchers alike in the selection of the most appro-
priate measure for their situation.
While measuring functional status is a complex
construct, not all measures could be easily categor-
ized into one theme. We found measures that overlap
between categories. Further, some aspects of FSMs
may not be considered “activity measures” by some.
For example, the chronic respiratory disease question-
naire (CRQ)22 dyspnea domain can be considered an
“impact” measure, as this most closely measures
function in the CRQ (see Surrogate category). On the
other hand, the Saint George’s Respiratory Question-
naire (SGRQ),61 also a health status measure, has an
“activity” as well as a symptom domain. However,
this domain queries about many symptoms, not only
dyspnea with an activity. Arguably, the dyspnea
domain of the CRQ could be an Impact-Based Mea-
sure because it asks patients to rate the severity of
their dyspnea with each activity. However, because
it is a subscale of the CRQ, we determined it best fit
with other Surrogate Measures. On the other hand,
the Medical Research Council Modified version
(mMRC) with 5 grades (0–4)46,172 has been used as
both a measure of dyspnea and disability.47,95 While
more commonly known as a dyspnea measure, the
mMRC evaluates the impact of dyspnea on activity
levels (primarily walking) and therefore meets our
criteria for an Impact-Based Measure. However, the
mMRC could also arguably be justified as a disability
measure because the grades provide a distinct indica-
tion of impairment, that is, activity limitation (breath-
lessness only with strenuous exercise) to severe
limitation (too breathless to leave the home). In inter-
preting the categorization, clinicians and researchers
therefore may select an FSM based on the overlap.
This could be of particular use when more than one
domain or construct is to be measured, saving patients
time in completing only one tool instead of multiple.
While the creation of this framework and categoriza-
tion of FSMs has attempted to simplify selection of
instruments, extensive consideration by clinicians and
researchers alike is still needed prior to selection of an
FSM to ensure that the most efficient and targeted tool
is indeed selected.
Table 7. Listing of FSMs by categories and identifying
categories with which they overlap(X).
Measuresa
Categories











































FSM: functional status measure. Shaded columns indicate the
activities within the respective categories.
aRefer to Table 1 for abbreviations of FSMs.
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Psychometric testing is a critical feature to a strong
instrument and issues of reliability, validity, and
responsiveness should have been demonstrated, and
through this review a summary of these properties has
been synthesized for clinicians to access. Where psy-
chometric properties of an instrument are not avail-
able in the literature, further research should be
completed prior to clinical application of the tool. The
framework presented in this article provides informa-
tion only on tools that have been assessed, and there-
fore, this article is intended as one of many resources
for clinicians to draw on.
The available FSMs to date have predominantly
been developed and evaluated in English language
countries with European-based cultures, and this
should be considered when selecting a measure. Some
activities identified in the original development of the
instruments may not be relevant for some countries/
cultures/genders/age groups. For example, FSMs con-
taining activities such as soccer, shoveling snow, and
ice skating may not be relevant to certain areas of the
world or to the elderly individual with moderate to
severe disease. Further, some instruments used
gender-specific terms or stereotypes to describe activ-
ities. This may result in significant missing data. In
the development of an instrument, there should be
virtually no missing data (i.e. the instrument must
make allowances for activities never performed, unre-
lated to COPD). On the other hand, if a study finds
missing data occurring, they should be vigilant for the
reasons for lack of response. For culturally responsive
and adaptable health-care practice, ethnocultural
interpretation of the measures should be evaluated
prior to selection for application, and research into
application of the FSMs to broader diverse commu-
nities is needed.
In evaluation of reading level of FSMs included in
this review, most instruments attempt to attain reading
at the 5th or 6th grade reading level (although not
always stated); however, the nature of terms used in
health care (e.g. breathlessness) may result in higher
than desirable reading levels and may impact the psy-
chometric properties of the FSMs. Understanding the
reading and health literacy of the population group
should also be a factor in selecting an instrument.
Health literacy is the level to which an individual has
the capacity to obtain, process, and understand basic
health information and health-care services available
to make informed decisions on health-care manage-
ment.173 Low levels of health literacy are readily
reported for people with COPD and are linked to
poorer health outcomes.174–176 Cognitive capacity
may also impact the ability to complete the FSM. The
incidence of cognitive impairment for people with
COPD is greater than the general population with
structural brain abnormalities, such as decreased hip-
pocampal volume,177 increased deep or infratentorial
microbleeds,178 and white matter lesions,179 being
more frequently evident. When measuring functional
status, should the patient’s reading, cognitive, and
literacy level be below that required, this could sig-
nificantly impact the psychometric properties of the
tool and lead to inaccurate information and conclu-
sions. Further, research in understanding the impact of
reading or literacy levels on the psychometric prop-
erties of FSMs is warranted to ensure that the tools are
valid and reliable across different cultural groups.
Conclusions
A diverse range of measures are available to the clin-
ician and researcher looking to evaluate functional
status for people with COPD. The establishment of
the many FSMs is likely related to the numerous rea-
sons for why functional status is measured for people
with COPD. Considering the diversity of measures
available for use, selection must be thoughtful based
on the nature of the population being studied, and
evaluation being conducted, not simply because it is
a standard at the institution. Psychometric testing is a
critical feature to a strong instrument and issues of
reliability, validity, and responsiveness need to be
understood prior to measurement use. Contextual
nature of measures such as language used and activ-
ities measured is also important. One approach to
categorizing FSMs was presented to include daily
activities measures, impact measures, surrogate mea-
sures, indirect performance-based measures, and
disability-based measures. A summary of design and
psychometric properties of the measures was pro-
vided as a guide to clinicians and researchers in the
selection of the most appropriate application of a
measure.
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